AzTrials
AzTrials

Vision ScreeningNCT07208838

Validation of DDIVAT Digital Optotypes for Distance Visual Acuity Testing Among the Bulgarian Population

An observational study of Vision Screening, run by Plovdiv Medical University at 1 site in Bulgaria.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

To compare distance visual acuity in Bulgarian patients over 18 years of age using two different methods - the Snellen method and the DIDIVAT digital online optotypes. For the purpose of this study, it is planned to examine native visual acuity (with and without prescribed optical correction), without additional… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Vision Screening
What is being tested?
To test visual acuity in 150 Bulgarian patients over 18 years of age using Snellens visual acuity chart and DDIVAT optotypes
How many people
150 participants
Where
1 siteBulgaria
Study dates
1 Oct 2025to 1 Jul 2026
How long will I take part?
1 Day
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Bulgarian speaking patients (75 women and 75 men) over 18 years of age, hospitalized in a university eye clinic at St. George University Hospital and healthy volunteers willing to participate in the study.

Who may be able to join

  • Bulgarian speaking patients (75 women and 75 men) over 18 years of age, hospitalized in a university eye clinic at St. George University Hospital and healthy volunteers willing to participate in the study.

Who cannot join

  • Patients of less than 18 years of age.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Bulgaria1 site
  • Medical University Plovdiv

    Plovdiv, 4004

Other trials in Bulgaria

About this study

To compare distance visual acuity in Bulgarian patients over 18 years of age using two different methods - the Snellen method and the DIDIVAT digital online optotypes. For the purpose of this study, it is planned to examine native visual acuity (with and without prescribed optical correction), without additional mydriasis in both ways, of 150 Bulgarian patients (75 women and 75 men) over 18 years of age, hospitalized in a university eye clinic at St. George University Hospital and healthy volunteers willing to participate in the study. The statistical analysis that will be performed will aim to compare whether the two methods for determining distance visual acuity are identical in results, as well as to validate the application for the Bulgarian population.The study is expected to prove that the distance visual acuity of patients examined by both methods is identical.

Being tested
To test visual acuity in 150 Bulgarian patients over 18 years of age using Snellens visual acuity chart and DDIVAT optotypes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • To test visual acuity in 150 Bulgarian patients over 18 years of age using Snellens visual acuity chart and DDIVAT optotypesDiagnostic test

    The study compares newly developed visual acuity test (DDIVAT) with standart method for visual acuity testing used worldwide

Study groups in NCT07208838
Study groupRoleWhat they receive
Healthy participants75 males and 75 females over 18 years of age
Receives: Diagnostic Test: To test visual acuity in 150 Bulgarian patients over 18 years of age using Snellens visual acuity chart and DDIVAT optotypes

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The study is expected to prove that the distance visual acuity of patients examined by both methods is identical.

    Measured: 12 monts

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Oct 2025
  2. Study start1 Oct 2025 (estimated)
  3. Primary completion1 Jul 2026 (estimated)
  4. Study completion1 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
150 participants (estimated)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT07208838
Sponsor's protocol ID
PlovdivMUDDIVAT
Status last verified
Apr 2025
First submitted
28 Sep 2025
Last updated
6 Oct 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Publications

  • Bakirtzis M, Michaleakou E, Martidou ME, Lahana E, Kostagiolas P, Niakas D, Labiris G. Visual Acuity Screening of Refugees and Immigrants with a Web-Based Digital Test: A Pilot Study. Acta Medica (Hradec Kralove). 2024;67(3):79-86. doi: 10.14712/18059694.2025.2.

    PubMed 39963735
  • Labiris G, Panagiotopoulou EK, Duzha E, Tzinava M, Perente A, Konstantinidis A, Delibasis K. Development and Validation of a Web-Based Reading Test for Normal and Low Vision Patients. Clin Ophthalmol. 2021 Sep 22;15:3915-3929. doi: 10.2147/OPTH.S314943. eCollection 2021.

    PubMed 34588763
  • Labiris G, Panagiotopoulou EK, Chatzimichael E, Tzinava M, Mataftsi A, Delibasis K. Introduction of a digital near-vision reading test for normal and low vision adults: development and validation. Eye Vis (Lond). 2020 Oct 22;7:51. doi: 10.1186/s40662-020-00216-0. eCollection 2020.

    PubMed 33102611
  • Labiris G, Panagiotopoulou EK, Delibasis K, Duzha E, Bakirtzis M, Panagis C, Boboridis K, Mokka A, Balidis M, Damtsi C, Ntonti P. Validation of a web-based distance visual acuity test. J Cataract Refract Surg. 2023 Jul 1;49(7):666-671. doi: 10.1097/j.jcrs.0000000000001176.

    PubMed 36853857

Questions about this trial

What is this clinical trial studying?

An observational study of Vision Screening, run by Plovdiv Medical University at 1 site in Bulgaria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 6 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Bulgaria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The study is expected to prove that the distance visual acuity of patients examined by both methods is identical. (time frame: 12 monts). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07208838, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in